Journal of Clinical Lipidology
Volume 3, Issue 2 , Pages 146-148 , April 2009

The first recorded heterozygote for familial hypercholesterolemia

Received 30 January 2009 ,Accepted 5 February 2009.

References 

  1. Ose L. The real code of Leonardo da Vinci. Curr Cardiol Rev. 2008;4:60–62
  2. Dequeker J, Muls E, Leenders K. Xanthelasma and lipoma in Leonardo da Vinci's Mona Lisa. Isr Med. Assoc J. 2004;6:505–556
  3. Rayer P. Traite des maladies de la peau. Paris: J. Balliere; 1835;
  4. Addison T, Gull W. On a certain affection of the skin. Guys Hosp Rep. 1851;7:2
  5. Gull W. Vitiligoidea; a-plana, β-tuberosa. Guys Hosp Rep. 1852;8:149–151
  6. Durrington PN. Dyslipidaemia. Lancet. 2003;362:717–731
  7. Erkelens DW, Sherwood LM. Familial hypercholesterolemia, tendinous xanthomata and Frans Hals. JAMA. 1989;265:2092
  8. Portrait of an elderly lady. Available at: http://www.abcgallery.com/H/hals/hals23.html. Accessed February 20, 2009.
  9. Sijbrands EJ, Westendorp RG, Defesche JC, de Meier PH, Smelt AH, Kastelein JJ. Mortality over two centuries in large pedigree with familial hypercholesterolemia: family tree mortality study. BMJ. 2001;322:1019–1023
  10. Burns FS. A contribution to the study of the etiology of xanthoma. Arch Derm Syph. 1920;2:415–429
  11. Thannhauser SJ, Magendanta H. The different clinical groups of xanthomatous diseases: a clinical physiological study of 22 cases. Ann Intern Med. 1938;11:1662–1746
  12. Müller C. Angina pectoris in hereditary xanthomatosis. Arch Intern Med. 1939;64:675–700
  13. Goldstein JL, Hobbs HH, Brown MD. Familial hypercholesterolaemia. In:  Scriver CR,  Beaudet AL,  Sly WS,  Valle D editor. The metabolic and molecular bases of inherited disease. 8th Ed. New York: McGraw-Hill; 2001;p. 2863–2913
  14. Charioteer of Delphi. Available at: http://en.wikepedia.org/wiki/Charioteer_of_Delphi. Accessed February 20, 2009.
  15. Durrington PN. Familial hypercholesterolaemia. Hyperlipidaemia. Diagnosis and management. London: Hodder Arnold; 2007;92–124
  16. Humphries SE, Norbury G, Leigh S, Hadfield SG, Nair D. What is the clinical utility of DNA testing in patients with familial hypercholesterolaemia?. Curr Opin Lipidol. 2008;19:362–368
  17. Williams RR, Hasstedt SJ, Wilson DE, et al. Evidence that men with familial hypercholesterolemia can avoid early coronary death. An analysis of 77 gene carriers in four Utah pedigrees. JAMA. 1986;255:219–224
  18. Pimstone SN, Sun X-M, Du Souich C, Frohlich JJ, Hayden MR, Soutar AK. Phenotypic variation in heterozygous familial hypercholesterolemia: a comparison of Chinese patients with the same or similar mutations in the LDL-receptor gene in China or Canada. Arterioscler Thromb Vasc Biol. 1998;18:309–315
  19. Willnow TE, Hammes A, Eaton S. Lipoproteins and their receptors in embryonic development: more than cholesterol clearance. Development. 2007;134:3239–3249
  20. Woollett LA. Where does fetal and embryonic cholesterol originate and what does it do?. Annu Rev Nutr. 2008;28:97–114
  21. Suh JM, Gao X, McKay J, Salo Z, Graff JM. Hedgehog signaling plays a conserved role in inhibiting fat formation. Cell Metab. 2006;3:25–34
  22. Beeharry D, Coupe B, Benbow EW, et al. Familial hypercholesterolaemia commonly presents with Achilles tenosynovitis. Ann Rheum Dis. 2006;65:312–315
  23. Fouchier SW, Kastelein JP, Defesche JC. Update of the molecular basis of familial hypercholesterolaemia in The Netherlands. Hum Mutat. 2005;26:550–556
  24. Wierzbicki AS, Humphries SE, Minhans R. Familial hypercholesterolaemia: summary of NICE guidance. BMJ. 2008;337:509–510.
  25. Neil A, Cooper J, Betteridge J, et al. Reductions in all-cause, cancer and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J. 2008;29:2625–2633

PII: S1933-2874(09)00077-4

doi: 10.1016/j.jacl.2009.02.002

Journal of Clinical Lipidology
Volume 3, Issue 2 , Pages 146-148 , April 2009

Article Tools

* Image Usage & Resolution